Semantic Computing Lab, Data Analytics Department, Institute for Infocomm Research (I2R), 119613, Singapore.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):408-17. doi: 10.2174/18715273113126660156.
Diabetes mellitus (DM) is characterized by hyperglycemia either due to deficient insulin production (Type 1 Diabetes mellitus) or peripheral insulin resistance of the cells (Type 2 Diabetes mellitus). Both Type 1 Diabetes mellitus and Type 2 Diabetes mellitus are more prevalent and efforts are directed to actively control these metabolic syndromes. Currently, Alzheimer's disease (AD), is gaining popularity as 'Type 3 diabetes' or 'Diabetes of the brain' and it is now evident that this neurodegenerative disease has multiple shared pathology with DM. Alarming is the fact that the incidence of AD might double within the next two decades, and this is certain to cause devastating effects not only to the afflicted individual or the family, but also to the global economy. Methods to either delay the onset or inhibit the progression of AD are therefore necessary. Progressive dementia, increased deposition of amyloid- β protein, neurofibrillary tangles and neuritic plaques in the brain are some of the hallmarks of AD. More understanding of the disease at the cellular and molecular level will enable identifying the possible targets for intervention and pave way for either development of novel or modification of the existing therapeutic options. In this work we have performed semantic data mining analysis on a large collection of most recently published data and identified an updated list of common genes expressed in DM and AD. Functional analysis of these genes revealed both existing and missing links involved in a bigger network associated with both disease conditions. Thus we argue that computational analysis methods help not only in understanding the mechanistic links but also in narrowing down precise targets (genes, proteins, metabolites and signalling pathways) and provide the base for both disease intervention and development of therapeutic options.
糖尿病(DM)的特征是高血糖,要么是由于胰岛素分泌不足(1 型糖尿病),要么是细胞外周胰岛素抵抗(2 型糖尿病)。1 型糖尿病和 2 型糖尿病都更为普遍,人们正在努力积极控制这些代谢综合征。目前,阿尔茨海默病(AD)作为“3 型糖尿病”或“大脑糖尿病”而备受关注,现在很明显,这种神经退行性疾病与 DM 有多种共同的病理。令人震惊的是,AD 的发病率可能在未来二十年翻一番,这不仅会对患者个人或家庭造成毁灭性影响,也会对全球经济造成影响。因此,有必要寻找延缓 AD 发病或抑制其进展的方法。进行性痴呆、脑内淀粉样β蛋白沉积增加、神经原纤维缠结和神经纤维斑块是 AD 的一些特征。在细胞和分子水平上对该疾病有更多的了解,将有助于确定可能的干预靶点,并为开发新的治疗方法或修改现有的治疗方法铺平道路。在这项工作中,我们对最近发表的大量数据进行了语义数据挖掘分析,确定了一个在 DM 和 AD 中表达的常见基因的更新列表。对这些基因的功能分析揭示了与这两种疾病相关的更大网络中既有联系又有缺失的联系。因此,我们认为计算分析方法不仅有助于理解机制联系,还有助于缩小精确靶点(基因、蛋白质、代谢物和信号通路)的范围,并为疾病干预和治疗方法的发展提供基础。